Skip to main content
Premium Trial:

Request an Annual Quote

Wendy Blosser, Jasmine Gruia-Gray, Robin Cowie

Biodesix announced that it has hired Wendy Blosser as its new VP of sales, and has promoted Jasmine Gruia-Gray to the post of VP of marketing and Robin Cowie to the role of VP of reimbursement and healthcare economics.

Blosser joins the firm from Integrated Oncology, a subsidiary of Laboratory Corporation of America, where she held the position of US VP of sales. She also previously worked in sales at Vermillion and Precision Therapeutics.

Gruia-Gray joined Biodesix last year after serving as VP of global marketing for Affymetrix. Cowie joined Biodesix in 2011 as the firm's first director of reimbursement.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.